FDA Inspection
Maitland Labs of Central FloridaMaitland Labs of Central Florida – FDA Inspection, Feb 28, 2020
Record Details
This FDA Inspection record concerns Maitland Labs of Central Florida, with an inspection on February 28, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 28, 2020
- Product Type
- Drugs
View Company Profile
ID · 485733c1-76bf-43b8-b882-7e81ecc1e2b2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1119181
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
FDA Citations
7- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- Container label, outsourcer facility
- Drug product label, outsourcer facility
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Maitland Labs of Central Florida
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Maitland Labs of Central Florida
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.